Voyager Therapeutics Balance Sheet - Quarterly (NASDAQ:VYGR)

Add to My Stocks
$21.82 $0.04 (0.18%) VYGR stock closing price Mar 16, 2018 (Closing)

A balance sheet is one of the three key financial statements released by a publicly listed company like Voyager Therapeutics, and helps in stock analysis. Balance sheet items like cash at hand, total assets and liabilities helps one analyze a company and summarize the financial performance of the company like we have in our Voyager Therapeutics stock analysis. Good quarterly results indicate a company's strong financial performance. Its important to check all financial statements including the balance sheet. Voyager Therapeutics balance sheet as at the end of 2017 Q3 indicates an asset turnover ratio of 0.03 and debt to equity ratio of 0. Also check Voyager Therapeutics revenue and Voyager Therapeutics operating cash flow for the same period.

View and download Voyager Therapeutics quarterly results to get the balance sheet details for the latest 40 quarters data.
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q3
Marketable Securities77.38M75.02M114.06M137.77M127.64M136.96M170.09M163.02M41.13M
Raw Materials---------
Work In Progress---------
Finished Goods---------
Notes Receivable---------
Other Current Assets2.6M3.4M3.41M4.36M1.86M1.48M1.7M1.55M-
Total Current Assets
Property Plant & Equipment---9.28M---4.01M-
Accumulated Depreciation---1.39M-----
Net Property Plant & Equipment
Investment & Advances-1.48M2M1.36M2.41M-9.98M30M52.92M
Other Non-Current Assets---------
Deferred Charges---------
Deposits & Other Assets1.2M1.53M1.87M1.52M2.29M---1.62M
Total Assets
Notes Payable---2.92M-----
Accounts Payable------1.69M--
Current Portion Long-Term Debt---------
Current Portion Capital Leases---------
Accrued Expenses10.49M7.31M5.59M6.48M6.3M5.04M2.66M3.43M2.94M
Income Taxes Payable---------
Other Current Liabilities9.53M4.21M4.91M6.76M12.29M14.25M18.71M19.88M19.88M
Total Current Liabilities
Deferred Taxes/Income33.75M40.26M40.3M39.81M33.44M34.31M33.26M36.4M41.29M
Convertible Debt---------
Long-Term Debt---------
Non-Current Capital Leases---------
Other Long-Term Liabilities1.01M1.01M1.02M------
Total Liabilities
Minority Interest---------
Preferred Stock--------148.85M
Common Stock Net---------
Capital Surplus234.51M230.77M229M225.96M223.81M221.96M220.55M219.12M-
Retained Earnings-148.88M-125.53M-106.66M-90.01M-75.34M-66.34M-57.01M-49.82M-47.17M
Treasury Stock---------
Other Liabilities-0.45M---0.05M----0.25M-
Shareholders Equity85.2M105.29M122.69M135.92M149.12M155.7M163.59M169.07M101.71M
Total Liabilities & Shareholders Equity140.91M158.41M175.09M189.56M201.98M209.81M219.98M229.45M166.43M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

The latest Voyager Therapeutics stock price, and Voyager Therapeutics historical stock prices show the stock price movement over time, and the Voyager Therapeutics PE ratio chart displays the PE ratio movement. Apart from stock price, one should also look at balance sheet items which mainly comprise of the following:

  • Assets: An asset is a resource that a corporation like Voyager Therapeutics owns and has monetary significance. VYGR assets decreased from $158.41M in 2017 Q2 to $140.91M in 2017 Q3. Assets can be of two types: fixed assets like real estate, plant and machinery; and current assets which includes cash, accounts receivable etc. Tech stocks typically don't have too many assets.
  • Liabilities or obligations comprise of current liabilities that include short term loans, amounts payable to suppliers, or any other outstanding payments including long term liabilities that take into account long term loans for funding large projects. The total liabilities for Voyager Therapeutics is $55.7M. Shareholders equity comes under liabilities as it is money the company owes the holders of VYGR stock.

Voyager Therapeutics Balance Sheet - Key Ratios

Current ratio
Debt to equity ratio
Asset turnover ratio
Receivables turnover
Price to book ratio